Nurix Therapeutics Inc logo

Nurix Therapeutics Inc

NAS:NRIX (USA)   Ordinary Shares
$ 14.70 +0.16 (+1.1%) 04:00 PM EST
At Loss
P/B:
3.57
Market Cap:
$ 718.74M
Enterprise V:
$ 449.71M
Volume:
1.29M
Avg Vol (2M):
861.37K
Volume:
1.29M
At Loss
Avg Vol (2M):
861.37K

Business Description

Nurix Therapeutics Inc logo
Nurix Therapeutics Inc
NAICS : 541714 SIC : 2834
ISIN : US67080M1036

Share Class Description:

NRIX: Ordinary Shares
Description
Nurix Therapeutics Inc is a biopharmaceutical company focused on the discovery, development and commercialization of oral, small molecule therapies designed to modulate cellular protein levels as a novel treatment approach for cancer and immune disorders. The company's pipeline comprises targeted protein degraders of Brutons tyrosine kinase, or BTK, a B-cell signaling protein, and inhibitors of Casitas B-lineage lymphoma proto-oncogene-B, or CBL-B, an E3 ligase that regulates T cell activation. Its drug candidate from protein degradation portfolio, NX-2127, is an orally available BTK degrader for the treatment of relapsed or refractory B-cell malignancies. Its drug candidate from E3 ligase inhibitor portfolio, NX-1607, is an orally available CBL-B inhibitor for immuno-oncology indications.
Name Current Vs Industry Vs History
Cash-To-Debt 9.4
Equity-to-Asset 0.56
Debt-to-Equity 0.15
Debt-to-EBITDA -0.22
Interest Coverage N/A
N/A
N/A
Piotroski F-Score 3/9
0
1
2
3
4
5
6
7
8
9
Altman Z-Score 0.19
Distress
Grey
Safe
Beneish M-Score -2.86
Manipulator
Not Manipulator
WACC vs ROIC
WACC
ROIC
Name Current Vs Industry Vs History
5-Day RSI 70.05
9-Day RSI 64.18
14-Day RSI 63.26
6-1 Month Momentum % 42.79
12-1 Month Momentum % 31.13

Liquidity Ratio

Name Current Vs Industry Vs History
Current Ratio 3.4
Quick Ratio 3.4
Cash Ratio 3.31
Days Sales Outstanding 9.48

Dividend & Buy Back

Name Current Vs Industry Vs History
3-Year Average Share Buyback Ratio -7.8
Shareholder Yield % -0.11

Financials (Next Earnings Date:2024-04-12 Est.)

NRIX's 30-Y Financials
Income Statement Breakdown
No Enough Data
Balance Sheet Breakdown
No Enough Data
Cashflow Statement Breakdown
No Enough Data

Historical Operating Revenue by Business Segment

Historical Operating Revenue by Geographic Region

5-Step DuPont Analysis as of
No Enough Data

Guru Trades

See Details
To

Insider Trades

See Details
To

Gurus Latest Trades with NAS:NRIX

No Available Data

Peter Lynch Chart

Y-axis scale:
Interactive Chart
To

Performance

Dividend
Log
Bar
To

Annualized Return %  

Symbol
1 Week
1 Month
3 Months
6 Months
YTD
1 Year
3 Years
5 Years
10 Years

Total Annual Return %  

Symbol
2024
2023
2022
2021
2020
2019
2018
2017
2016
2015

Nurix Therapeutics Inc Executives

Details

Valuation Chart

Year:

Analyst Estimate

Key Statistics

Name Value
Revenue (TTM) (Mil $) 76.987
EPS (TTM) ($) -2.65
Beta 1.81
Volatility % 99.26
14-Day RSI 63.26
14-Day ATR ($) 1.100782
20-Day SMA ($) 13.711
12-1 Month Momentum % 31.13
52-Week Range ($) 4.22 - 16.11
Shares Outstanding (Mil) 48.89

Piotroski F-Score Details

Year:
Component Result
Piotroski F-Score 3
Positive ROA
Positive CFROA
Higher ROA yoy
CFROA > ROA
Lower Leverage yoy
Higher Current Ratio yoy
Less Shares Outstanding yoy
Higher Gross Margin yoy
Higher Asset Turnover yoy

Nurix Therapeutics Inc Filings

Filing Date Document Date Form
No Filing Data

Nurix Therapeutics Inc Stock Events

Financials Calendars
Event Date Price($)
No Event Data

Nurix Therapeutics Inc Frequently Asked Questions

What is Nurix Therapeutics Inc(NRIX)'s stock price today?
The current price of NRIX is $14.70. The 52 week high of NRIX is $16.11 and 52 week low is $4.22.
When is next earnings date of Nurix Therapeutics Inc(NRIX)?
The next earnings date of Nurix Therapeutics Inc(NRIX) is 2024-04-12 Est..
Does Nurix Therapeutics Inc(NRIX) pay dividends? If so, how much?
Nurix Therapeutics Inc(NRIX) does not pay dividend.

Press Release

Subject Date
No Press Release

Headlines

See More
  • 1
No news.
  • 1